Cite
HARVARD Citation
Zeng, Y. et al. (2022). AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. Journal of clinical laboratory analysis. 36 (6), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Zeng, Y. et al. (2022). AFF3 is a novel prognostic biomarker and a potential target for immunotherapy in gastric cancer. Journal of clinical laboratory analysis. 36 (6), p. n/a. [Online].